Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03024294
Other study ID # 2016P002308
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date December 2019

Study information

Verified date July 2018
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to create a unified SOP for care of subjects undergoing VATS lobectomy and segmentectomy by members of the Division of Thoracic Surgery. Other academic centers have created standardized algorithms for the care of their subjects and this enables the centers to determine which subjects can be placed on an accelerated pathway to discharge and which cannot. Some of these SOPS dictate uniform treatment algorithms with reduction in what may be unnecessary tests to simplify patient care and likely accelerate them towards safe and more timely discharge from the hospital.


Description:

This is a prospective, study to develop, test, fine-tune and refine an SOP for the post-operative care for patients who undergo a VATS lobectomy or segmentectomy performed by one of the surgeons in The Division of Thoracic Surgery. This study will be conducted in two phases. Phase 1 will be focused on early feasibility of the SOP and this will be done by enrolling 50 participants among the subgroup of Thoracic VATS Surgeons who participate. An analysis will take place upon the completion of the phase 1 to look at the percentage of participants who were able to be discharged on or prior to POD 3. Upon this analysis, modifications across all areas of the care pathway will be evaluated and altered if deemed necessary by the PI and other members of the study team. This analysis will drive any modifications needed that will be incorporated into the phase II design prior to its implementation. The treating Thoracic Surgeon for each patient will follow the SOP as it is outlined and the steps the post-operative team will follow will be dependent on which phase the participant is enrolled too. Data will be collected for each participant starting just prior to the VATS operation and continue through the discharge and conclude once the participants have reached their 90-day post-discharge date. Upon discharge from the hospital the participant will enter the follow-up period of the study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male and female subjects

- Age = 18 years

- Subjects planned to undergo a VATS lobectomy or segmentectomy procedure for lung nodules

Exclusion Criteria:

- Subjects who cannot undergo VATS surgery

- Subjects undergoing any kind of resection in addition to VATS Lobectomy or Segmentectomy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Post-operative care pathway for patients undergoing VATS lobectomy or segmentectomy
To place participants on this specific post-operative care pathway upon the completion of their VATS surgery to determine the discharge rate by midnight on post-operative day (POD) three.

Locations

Country Name City State
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary objective is to evaluate feasibility of this SOP in two phases. The primary objective of phase 1 is to determine the POD 3 rate, defined as proportion of patients who are discharged by midnight on POD 3. From date of consent until midnight of post op day 3
Primary The primary objective of phase II is to further evaluate this SOP. The study team will also have the opportunity to refine and fine tune this SOP between phase I and phase II. From date of consent until midnight of post op day 3
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05358041 - Cone Beam CT Guided Robotic Navigational Bronchoscopy
Recruiting NCT06123312 - Tri-modality Sampling Using Radial Probe Endobronchial Ultrasound for the Diagnosis of Peripheral Pulmonary Lesions N/A
Active, not recruiting NCT04250194 - Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration N/A
Terminated NCT01720186 - Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer N/A
Not yet recruiting NCT06054854 - Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
Recruiting NCT03685669 - Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
Completed NCT04315467 - Intraoperative Imaging of Pulmonary Nodules by SGM-101 Phase 1
Active, not recruiting NCT05046093 - Clinical Outcomes of Cryobiopsy for Peripheral Pulmonary Lesions - A Prospective Pilot Study N/A
Completed NCT04194333 - Cone Beam CT Guided Electromagnetic Navigational Bronchoscopy